We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nuveen S&P 500 Buy Write Income Fund | NYSE:BXMX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.01 | 0.07% | 13.62 | 13.64 | 13.53 | 13.64 | 114,860 | 22:09:41 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 25, 2022 (February 24, 2022)
NUVEEN S&P 500 BUY-WRITE INCOME FUND
(Exact name of registrant as specified in its charter)
Massachusetts | 811-21619 | 20-1590560 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) | ||
333 West Wacker Drive | ||||
Chicago, Illinois | 60606 | |||
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (800) 257-8787
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13-4(c)) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Common Stock | BXMX | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 | Regulation FD Disclosure. |
Amendment of By-Laws. On February 24, 2022, the Board of Trustees of Nuveen S&P 500 Buy-Write Income Fund, a registered closed-end management investment company (the Fund), adopted Amendment No. 1 (the Amendment) to the Amended and Restated By-Laws of the Fund. The Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference.
On February 24, 2022, the Fund issued a press release in connection with the adoption of the Amendment.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
3.1 | Amendment No. 1 to Amended and Restated By-Laws | |
99.1 | Press Release, dated February 24, 2022 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NUVEEN S&P 500 BUY-WRITE INCOME FUND | ||
By: | /s/ David J. Lamb | |
Name: | David J. Lamb | |
Title: | Chief Administrative Officer |
DATE: February 25, 2022
3
1 Year Nuveen S&P 500 Buy Write... Chart |
1 Month Nuveen S&P 500 Buy Write... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions